COVID-19
COVID-19 is a contagious disease caused by the coronavirus SARS-CoV-2, leading to symptoms such as fever, cough, and difficulty breathing, and can range from mild to severe illness.
COVID-19 Vaccine Booster Study: CD40.RBDv
We are testing a new bivalent COVID-19 vaccine to see if it safely boosts immunity in volunteers. This study will help us understand its effectiveness compared to existing vaccines.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Hopital De La Croix Rousse
Hospital de Lyon Nord – Croix Rousse
Caluire-et-Cuire, France
Assistance Publique Hopitaux De Paris
Department of Infectious Diseases & Clinical Immunology
Créteil, France
Assistance Publique Hopitaux De Paris
CIC1417 Paris Cochin
Maison Blanche, France
Sponsor: Inserm
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.